Vote to see vote counts
The potential for AI to extend human lifespan by targeting diseases like Alzheimer's is a promising area of research. Advances in biotechnology could lead to significant improvements in healthspan and quality of life.
Dr. Fagenbaum's AI platform has reviewed over 6,000 drug-disease matches, identifying promising treatments hiding in plain sight.
The idea that human DNA is a fractal antenna suggests we are capable of tuning into a vast array of signals, enhancing our understanding of human potential.
The idea that human DNA functions as a fractal antenna suggests a complex interaction with the environment, enhancing our understanding of human potential.
The implication of being able to edit DNA like software is that a human being is now a software engineering problem.
The AI system used by EveryCure can now process data in 17 hours, a significant improvement from the initial 100 days.
The concept of using advanced genetics to uncover historical narratives, similar to the premise of 'Assassin's Creed,' is a speculative but intriguing idea.
The AI system used by EveryCure took 100 days to run initially but now has a 17-hour turnaround time, significantly speeding up the process of finding potential drug-disease matches.
The necessity of large genomes in multicellular organisms is driven by the need to minimize genetic conflict between cells, ensuring that all cells work towards the same goal of survival and reproduction.
Dr. Fagenbaum's AI platform can now run analyses in 17 hours, down from 100 days, improving efficiency in drug repurposing.